Recombinant expression of coagulation factor VIII in hepatic and non-hepatic cell lines stably transduced with third generation lentiviral vectors comprising the minimal factor VIII promoter

References

• Hoyer LW. Hemophilia A. N Engl J Med 1994; 330: 38–47
   PubMed Web of Science ®Google Scholar
• Soucie JM, Evatt B, Jackson D. Occurrence of hemophilia in the United States. The Hemophilia Surveillance System Project Investigators. Am J Hematol 1998; 59: 288–94
   PubMed Web of Science ®Google Scholar
• Antonarakis SE, Kazazian HH, Gitschier J, et al. Molecular etiology of factor VIII deficiency in hemophilia A. Adv Exp Med Biol 1995; 386: 19–34
   Google Scholar
• Lofqvist T, Nilsson IM, Berntorp E, Pettersson H. Haemophilia prophylaxis in young patients: a long-term follow-up. J Intern Med 1997; 241: 395–400
   PubMed Web of Science ®Google Scholar
• Fakharzadeh SS, Kazazian HH, Jr. Correlation between factor VIII genotype and inhibitor development in hemophilia A. Semin Thromb Hemost 2000; 26: 167–71
   PubMed Web of Science ®Google Scholar
• Ponder KP. Gene therapy for hemophilia. Curr Opin Hematol 2006; 13: 301–7
   Google Scholar
• Pierce GF, Lillicrap D, Pipe SW, Vandendriessche T. Gene therapy, bioengineered clotting factors and novel technologies for hemophilia treatment. J Thromb Haemost 2007; 5: 901–6
   PubMed Web of Science ®Google Scholar
• Wion KL, Kelly D, Summerfield JA, et al. Distribution of factor VIII mRNA and antigen in human liver and other tissues. Nature 1985; 317: 726–9
   PubMed Web of Science ®Google Scholar
• Grimm D, Zhou S, Nakai H, et al. Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy. Blood 2003; 102: 2412–9
   PubMed Web of Science ®Google Scholar
• Verhoeyen E, Cosset FL. Surface-engineering of lentiviral vectors. J Gene Med 2004; 6(Suppl 1)S83–94
   Google Scholar
• Miao CH, Ohashi K, Patijn GA, et al. Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro. Mol Ther 2000; 1: 522–32
   PubMed Web of Science ®Google Scholar
• Notley C, Killoran A, Cameron C, et al. The canine factor VIII 3′-untranslated region and a concatemeric hepatocyte nuclear factor 1 regulatory element enhance factor VIII transgene expression in vivo. Hum Gene Ther 2002; 13: 1583–93
   PubMed Web of Science ®Google Scholar
• Mingozzi F, Liu YL, Dobrzynski E, et al. Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer. J Clin Invest 2003; 111: 1347–56
   PubMed Web of Science ®Google Scholar
• Philippe S, Sarkis C, Barkats M, et al. Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo. Proc Natl Acad Sci USA 2006; 21: 17684–9
   Google Scholar
• Nash KL, Jamil B, Maguire AJ, et al. Hepatocyte-specific gene expression from integrated lentiviral vectors. J Gene Med 2004; 6: 974–83
   PubMed Web of Science ®Google Scholar
• Van Damme A, Thorrez L, Ma L, et al. Efficient lentiviral transduction and improved engraftment of human bone marrow mesenchymal cells. Stem Cells 2006; 24: 896–907
   PubMed Web of Science ®Google Scholar
• Kootstra NA, Matsumura R, Verma I. Efficient production of human FVIII in hemophilic mice using lentiviral vectors. Mol Ther 2003; 7: 623–31
   PubMed Web of Science ®Google Scholar
• Modlich U, Bohne J, Schmidt M, et al. Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity. Blood 2006; 108: 2545–53
   PubMed Web of Science ®Google Scholar
• Baum C, Kustikova O, Modlich U, et al. Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. Hum Gene Ther 2006; 17: 253–63
   PubMed Web of Science ®Google Scholar
• Mastromarino P, Conti C, Goldoni P, et al. Characterization of membrane components of the erythrocyte involved in vesicular stomatitis virus attachment and fusion at acidic pH. J Gen Virol 1987; 68: 2359–69
   PubMed Web of Science ®Google Scholar
• Molmenti EP, Perlmutter DH, Rubin DC. Cell-specific expression of alpha 1-antitrypsin in human intestinal epithelium. J Clin Invest 1993; 92: 2022–34
   Google Scholar
• Okuyama T, Huber RM, Bowling W, et al. Liver-directed gene therapy: a retroviral vector with a complete LTR and the ApoE enhancer-alpha 1-antitrypsin promoter dramatically increases expression of human alpha 1-antitrypsin in vivo. Hum Gene Ther 1996; 7: 637–45
   PubMed Web of Science ®Google Scholar
• Miyoshi H, Blomer U, Takahashi M, et al. Development of a self-inactivating lentivirus vector. J Virol 1998; 72: 8150–7
   PubMed Web of Science ®Google Scholar
• Stein CS, Kang Y, Sauter SL, et al. In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors. Mol Ther 2001; 3: 850–6
   PubMed Web of Science ®Google Scholar
• Follenzi A, Battaglia M, Lombardo A, et al. Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice. Blood 2004; 103: 3700–9
   PubMed Web of Science ®Google Scholar
• Salani B, Damonte P, Zingone A, et al. Newborn liver gene transfer by an HIV-2-based lentiviral vector. Gene Ther 2005; 12: 803–14
   Google Scholar
• Tonn T, Herder C, Becker S, et al. Generation and characterization of human hematopoietic cell lines expressing factor VIII. J Hematother Stem Cell Res 2002; 11: 695–704
   PubMedGoogle Scholar
• Herder C, Tonn T, Oostendorp R, et al. Sustained expansion and transgene expression of coagulation factor VIII-transduced cord blood-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2003; 23: 2266–72
   PubMed Web of Science ®Google Scholar
• Follenzi A, Naldini L. Generation of HIV-1 derived lentiviral vectors. Methods Enzymol 2002; 346: 454–65
   PubMed Web of Science ®Google Scholar
• Follenzi A, Naldini L. HIV-based vectors. Preparation and use. Methods Mol Med 2002; 69: 259–74
   PubMedGoogle Scholar
• McGlynn LK, Mueller CR, Begbie M, et al. Role of the liver-enriched transcription factor hepatocyte nuclear factor 1 in transcriptional regulation of the factor V111 gene. Mol Cell Biol 1996; 16: 1936–45
   PubMedGoogle Scholar
• Kalsheker N, Morley S, Morgan K. Gene regulation of the serine proteinase inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin. Biochem Soc Trans 2002; 30: 93–8
   PubMed Web of Science ®Google Scholar
• Mendel DB, Hansen LP, Graves MK, et al. HNF-1 alpha and HNF-1 beta (vHNF-1) share dimerization and homeo domains, but not activation domains, and form heterodimers in vitro. Genes Dev 1991; 5: 1042–56
   PubMed Web of Science ®Google Scholar
• Zufferey R, Nagy D, Mandel RJ, et al. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 1997; 15: 871–5
   PubMed Web of Science ®Google Scholar
• Donath MS, Lenting PJ, van Mourik JA, Mertens K. The role of cleavage of the light chain at positions Arg1689 or Arg1721 in subunit interaction and activation of human blood coagulation factor VIII. J Biol Chem 1995; 270: 3648–55
   Google Scholar
• Piacibello W, Bruno S, Sanavio F, et al. Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice. Nonobese diabetic/severe combined immunodeficient. Blood 2002; 100: 4391–400
   PubMed Web of Science ®Google Scholar
• Perlmutter DH, Cole FS, Kilbridge P, et al. Expression of the alpha 1-proteinase inhibitor gene in human monocytes and macrophages. Proc Natl Acad Sci USA 1985; 82: 795–9
   PubMed Web of Science ®Google Scholar
• Gorecki DC. Prospects and problems of gene therapy: an update. Expert Opin Emerg Drugs 2001; 6: 187–98
   PubMedGoogle Scholar
• Follenzi A, Ailles LE, Bakovic S, et al. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 2000; 25: 217–22
   PubMed Web of Science ®Google Scholar
• Persons DA, Hargrove PW, Allay ER, et al. The degree of phenotypic correction of murine beta-thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy number. Blood 2003; 101: 2175–83
   PubMed Web of Science ®Google Scholar
• Zielske SP, Lingas KT, Li Y, Gerson SL. Limited lentiviral transgene expression with increasing copy number in an MGMT selection model: lack of copy number selection by drug treatment. Mol Ther 2004; 9: 923–31
   PubMed Web of Science ®Google Scholar
• Persons DA, Allay ER, Sawai N, et al. Successful treatment of murine beta-thalassemia using in vivo selection of genetically modified, drug-resistant hematopoietic stem cells. Blood 2003; 102: 506–13
   PubMed Web of Science ®Google Scholar
• Do H, Healey JF, Waller EK, Lollar P. Expression of factor VIII by murine liver sinusoidal endothelial cells. J Biol Chem 1999; 274: 19587–92
   PubMed Web of Science ®Google Scholar
• Hollestelle MJ, Thinnes T, Crain K, et al. Tissue distribution of factor VIII gene expression in vivo: a closer look. Thromb Haemost 2001; 86: 855–61
   PubMed Web of Science ®Google Scholar
• Langley PG, Hughes RD, Williams R. Increased factor VIII complex in fulminant hepatic failure. Thromb Haemost 1985; 54: 693–6
   PubMedGoogle Scholar
• Doering CB, Josephson CD, Craddock HN, Lollar P. Factor VIII expression in azoxymethane-induced murine fulminant hepatic failure. Blood 2002; 100: 143–7
   Google Scholar
• Kay MA, Baley P, Rothenberg S, et al. Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc Natl Acad Sci USA 1992; 89: 89–93
   PubMed Web of Science ®Google Scholar
• Kay MA, Li Q, Liu TJ, et al. Hepatic gene therapy: persistent expression of human alpha 1-antitrypsin in mice after direct gene delivery in vivo. Hum Gene Ther 1992; 3: 641–7
   PubMed Web of Science ®Google Scholar
• Wilson JM, Chowdhury NR, Grossman M, et al. Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes. Proc Natl Acad Sci USA 1990; 87: 8437–41
   PubMed Web of Science ®Google Scholar
• Stein S, Siler U, Ott MG, et al. Gene therapy for chronic granulomatous disease. Curr Opin Mol Ther 2006; 8: 415–22
   Google Scholar
• Thrasher AJ, Gaspar HB, Baum C, et al. Gene therapy: X-SCID transgene leukaemogenicity. Nature 2006; 443: E5–7
   Web of Science ®Google Scholar
• Ott MG, Schmidt M, Schwarzwaelder K, et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 2006; 12: 401–9
   PubMed Web of Science ®Google Scholar
• Modlich U, Kustikova OS, Schmidt M, et al. Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis. Blood 2005; 105: 4235–46
   PubMed Web of Science ®Google Scholar